Taysha Gene Therapies, Inc. TSHA Proceeds from issuance of common stock relating to employee stock plans
Proceeds from issuance of common stock relating to employee stock plans at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromStockPlans.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s proceeds from issuance of common stock relating to employee stock plans.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s proceeds from issuance of common stock relating to employee stock plans?
- Taysha Gene Therapies, Inc. (TSHA) reported proceeds from issuance of common stock relating to employee stock plans of $176K in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s proceeds from issuance of common stock relating to employee stock plans changed year-over-year?
- Taysha Gene Therapies, Inc.'s proceeds from issuance of common stock relating to employee stock plans increased by 134.7% year-over-year, from $75K to $176K.